These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25294585)

  • 1. Schistosomes versus platelets.
    Da'dara AA; Skelly PJ
    Thromb Res; 2014 Dec; 134(6):1176-81. PubMed ID: 25294585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of qualitative and quantitative platelet abnormalities in schistosomiasis.
    Abdelfattah A; Hijjawi NS; Jacoub K
    Parasitol Res; 2024 May; 123(5):225. PubMed ID: 38809265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Participation of the IgE receptor in the toxicity of blood platelets against schistosomes].
    Joseph M; Ameisen JC; Kusnierz JP; Pancré V; Capron M; Capron A
    C R Acad Sci III; 1984; 298(3):55-60. PubMed ID: 6231973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Essential Ectoenzyme SmNPP5 from the Human Intravascular Parasite Schistosoma mansoni is an ADPase and a Potent Inhibitor of Platelet Aggregation.
    Elzoheiry M; Da'dara AA; deLaforcade AM; El-Beshbishi SN; Skelly PJ
    Thromb Haemost; 2018 Jun; 118(6):979-989. PubMed ID: 29669386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of schistosomes and schistosomiasis on murine blood coagulation and fibrinolysis as determined by thromboelastography (TEG).
    Da'dara AA; de Laforcade AM; Skelly PJ
    J Thromb Thrombolysis; 2016 May; 41(4):671-7. PubMed ID: 26573180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosome immunomodulators.
    Acharya S; Da'dara AA; Skelly PJ
    PLoS Pathog; 2021 Dec; 17(12):e1010064. PubMed ID: 34969052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosome tegumental ecto-apyrase (SmATPDase1) degrades exogenous pro-inflammatory and pro-thrombotic nucleotides.
    Da'dara AA; Bhardwaj R; Ali YB; Skelly PJ
    PeerJ; 2014; 2():e316. PubMed ID: 24711968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic aspects of schistosomiasis.
    Capron A; Dessaint JP
    Annu Rev Med; 1992; 43():209-18. PubMed ID: 1580585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular schistosomes and complement.
    Skelly PJ
    Trends Parasitol; 2004 Aug; 20(8):370-4. PubMed ID: 15246320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new function for platelets: IgE-dependent killing of schistosomes.
    Joseph M; Auriault C; Capron A; Vorng H; Viens P
    Nature; 1983 Jun; 303(5920):810-2. PubMed ID: 6866081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view.
    Capron A; Dessaint JP
    Annu Rev Immunol; 1985; 3():455-76. PubMed ID: 2933049
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
    James SL; Sher A; Lazdins JK; Meltzer MS
    J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils.
    Aktan I; Dunkel B; Cunningham FM
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):209-17. PubMed ID: 23332730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of innate antigen-presenting cell function by pre-patent schistosome infection.
    Ferragine CE; Walls CD; Davies SJ
    PLoS Negl Trop Dis; 2013; 7(3):e2136. PubMed ID: 23556020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New functions for platelets and their pathological implications.
    Capron A; Ameisen JC; Joseph M; Auriault C; Tonnel AB; Caen J
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):107-14. PubMed ID: 2989184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosome glycoconjugates in host-parasite interplay.
    Hokke CH; Deelder AM
    Glycoconj J; 2001 Aug; 18(8):573-87. PubMed ID: 12376724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity to schistosomes. Evaluation of mechanisms operating against lung-stage parasites which might be exploited in a vaccine.
    Pemberton RM; Malaquias LC; Falcao PL; Silveira AM; Rabello AL; Katz N; Amorim M; Mountford AP; Coffman RL; Correa-Oliveira R
    Trop Geogr Med; 1994; 46(4 Spec No):247-54. PubMed ID: 7825229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosome apyrase SmATPDase1, but not SmATPDase2, hydrolyses exogenous ATP and ADP.
    Da'dara AA; Bhardwaj R; Skelly PJ
    Purinergic Signal; 2014 Dec; 10(4):573-80. PubMed ID: 24894599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasite glycans and antibody-mediated immune responses in Schistosoma infection.
    van Diepen A; Van der Velden NS; Smit CH; Meevissen MH; Hokke CH
    Parasitology; 2012 Aug; 139(9):1219-30. PubMed ID: 22423613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse genetics and the study of the immune response to schistosomes.
    Pearce EJ; Freitas TC
    Parasite Immunol; 2008 Apr; 30(4):215-21. PubMed ID: 18324924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.